DeutschNewstral
Article
Bbarrons.com on 2019-06-07 17:33
Teva and J&J Stocks Were Hit by Opioid Worries. What Could Come Next.
Related news
- BTeva and Other Opioid Defendant Stocks Jump on Strong Earningsbarrons.com
J&J Liable for $572m in U.S. Opioid Epidemic Trial, but Teva, Other Drug Makers' Shares SurgeHaaretz
J&J, Teva beat $50 billion opioid case in first industry win - Wed, 03 Nov 2021 PSTThe Spokesman-Review- BTeva Stock Keeps Sinking Because Opioid Lawsuits Aren't Going Awaybarrons.com
- BTeva Reaches Tentative $23 Billion Deal to Settle Opioid Casesbarrons.com
- MMcKesson, Cardinal Health, Amerisource Bergen and Teva stocks all fall after settling with Ohio counties on opioid suitmarketwatch.com
- BTeva and Endo Are Falling Because Opioid Suits Aren't Going Awaybarrons.com
- Israel's Teva Plunges on Opioid Settlement, Bezeq on Write-off WoesHaaretz
- HOklahoma, Teva Pharmaceuticals Reach $85 Million Settlement in Opioid Casehamodia.com
Teva settles with Oklahoma for $85 million in opioid casetimesofisrael.com
Allergan, Teva to pay $54M in San Francisco opioid lawsuitdailyherald.com- Local governments reject opioid settlement from Teva, other drugmakeerstimesofisrael.com
- Oklahoma judge wants more answers on $85M Teva opioid settlementtimesofisrael.com
Teva reaches settlement with Oklahoma to resolve opioid claimsbizjournals.com
J&J opioid ruling tossed in OklahomaArkansas Online- BOpioid Stocks Fall as Purdue Announces Settlement, Bankruptcybarrons.com
Teva stocks fall 17.5%israelnationalnews.com
The Latest: Oklahoma judge finds J&J fueled opioid crisisreviewtimes.com